1. Home
  2. ANGI vs ALEC Comparison

ANGI vs ALEC Comparison

Compare ANGI & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Angi Inc.

ANGI

Angi Inc.

N/A

Current Price

$4.76

Market Cap

198.7M

ML Signal

N/A

Logo Alector Inc.

ALEC

Alector Inc.

N/A

Current Price

$2.12

Market Cap

275.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ANGI
ALEC
Founded
1995
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
198.7M
275.8M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
ANGI
ALEC
Price
$4.76
$2.12
Analyst Decision
Buy
Buy
Analyst Count
7
6
Target Price
$17.00
$4.83
AVG Volume (30 Days)
732.9K
1.5M
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
1242.86
N/A
EPS
N/A
N/A
Revenue
$736,386,000.00
$21,045,000.00
Revenue This Year
$3.25
$2.03
Revenue Next Year
$3.76
$29.87
P/E Ratio
N/A
N/A
Revenue Growth
47.60
N/A
52 Week Low
$4.26
$1.09
52 Week High
$18.38
$3.40

Technical Indicators

Market Signals
Indicator
ANGI
ALEC
Relative Strength Index (RSI) 48.39 48.46
Support Level $4.55 $1.93
Resistance Level $6.52 $2.64
Average True Range (ATR) 0.28 0.20
MACD 0.03 -0.06
Stochastic Oscillator 45.21 20.39

Price Performance

Historical Comparison
ANGI
ALEC

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Share on Social Networks: